Board of Directors

• Patrick K. Donnelly

  • Career Profile

    Executive chairman

    • 25+ years pharma services founder and executive

    C-level experience

    • Chairman and CEO of Advarra, Inc. until 2020
    • Chairman and CEO, from initial formation and sale, of Aptiv Solutions from 2009 to 2014
    • PRA International (now PRA Health Sciences, NASDAQ: PRAH) with three other partners, serving as CFO, COO, and CEO over the span of 14 years, taking PRA public in 2004

    Integration trailblazer

    • Initiated and closed over 39 acquisitions and global integrations and eight separate successful exit transactions, averaging over 4x investors’ money

    Education

    • Master of Business | Pennsylvania State University
    • Bachelor of Science in Business and Journalism | University of Missouri

• David Adair, M.D., MBA

  • Career Profile

    • 20+ years as an angel and venture capital investor
    • Founding member of Solas BioVentures

    INVESTMENT DRIVEN

    • He has led investments and served on the boards of Francis Medical, Biostable S&E, Arrivo Bio Ventures, NX Prenatal, Elira, InterShunt Technologies, AEGEA Medical (acquired by Cooper Surgical), Veran Medical Technologies (acquired by Olympus Corporation of America), Addrenex (acquired by Sciele/Shionogi), NeuroNex (acquired by Acorda), Velo Bio (acquired by AMAG Pharmaceuticals), Aerial Bio (acquired by Jazz Pharmaceuticals), NxThera (acquired by Boston Scientific), and Knopp BioSciences (asset purchase by Biohaven Pharmaceutical)

    TECHNOLOGY PIONEER

    • He is also an inventor and prior c-suite operator of a device and pharmaceutical startup

    CLINICAL LEADER

    • 20+ years as a practicing physician and as a professor and vice chairman of the department of obstetrics and gynecology at the University of Tennessee College of Medicine

    Education

    • M.D | Joan C. Edwards College of Medicine at Marshall University
    • MBA | Gary W. Rollins School of Business at the University of Tennessee, Chattanooga
    • Bachelor of Science in Biology | from Morehead State University

• Darren M. Black

  • Career Profile

    • Years of experience in the healthcare and life sciences sector
    • Managing director at Summit Partners

    HEALTHCARE INNOVATOR

    Managing partner with SV Life Sciences, was co-founder and president of two companies — ClinCare and PharmaStar — and served as a healthcare consultant for Accenture

    EXECUTIVE LEADERSHIP

    Darren’s current board directorships include InnovaCare Partners, Leon Medical Centers, LifeStance Health, Paradigm Outcomes, PharmScript, Sound Physicians, TurningPoint Healthcare Solutions, U.S. Renal Care, and VaxCare, in addition to Veranex

    Education

    • MBA | Wharton School of the University of Pennsylvania
    • Bachelor of Arts in Government | Harvard College

• Ali Dowd

  • Career Profile

    • Vice President at Summit Partners
    • Focused primarily on the healthcare and life sciences sector

    OPPORTUNITY FINDER

    Prior to Summit, Ali worked in the Healthcare Group at Thomas H. Lee Partners utilizing key competencies including strategy, data analysis and due diligence. Previously, she worked at TA Associates and BlackArch Partners

    Education

    • Bachelor of Arts in Economics | Vanderbilt University

• Uri Geiger, PH.D

  • Career Profile

    • 30+ years extensive entrepreneurial, management and investment know-how
    • Founder of Accelmed

    INNOVATION ORIGINATOR

    • CEO of Exalenz Bioscience Ltd. (TASE:EXEN), developer of an innovative breath-based technology for diagnosing liver and gastrointestinal disorders which Dr. Geiger took public in 2007 and later sold to Meridian (NASDAQ: VIVO)
    • Co-founded and CEO of GalayOr Networks, a developer of optical components, sold in 2003 to MEMSCAP (EuroNext: MEMS)
    • Founding partner of Dragon Variation Fund, one of Israel’s first hedge funds, which was sold to Migdal in 2007

    CAPITAL EXPERTISE

    • Profession on Wall Street during the 1990s, where he gained a broad understanding of capital markets and significant experience, which he put to use after returning to Israel in 1999
    • Former adjunct professor at the Recanati Business School at Tel Aviv University, where he lectured on private equity and venture capital

    AUTHOR

    • Startup Companies and Venture Capital (Tel Aviv University Press, 2001) and From Concept to Wall Street (Financial Times – Prentice Hall, 2003)

    COMMUNITY BUILDER

    • Dr. Geiger is also involved in an extensive philanthropic activity and is the Founder & Chairman of Friends of Poriya Medical Center in the US

    Education

    • PHD in Global Equity Markets | Columbia University Center for Law & Economics
    • Major | Israeli Air Force.

• Samuel Levy

  • Career Profile

    • Samuel is a physician entrepreneur
    • Founder of Allurion and Founding Partner at Lauxera Capital

    CONSULTANT

    • He started his career as a management consultant at McKinsey & Company in New York before moving to Boston to attend Harvard Medical School

    CLINICAL TRAILBLAZER

    • As a second-year medical student, Samuel co-founded Allurion Technologies and built a fully-integrated, global medical device company from the idea stage to commercialization in more than 30 countries

    Education

    • M.D. | Harvard Medical School
    • Bachelor of Science in Molecular Biophysics and Biochemistry | Yale University
    • Fulbright Scholar | Pasteur Institute

• Marshall S. Stanton, M.D.

  Career Profile

  • 30+ years as a senior executive in healthcare focused on medical device
  • Senior VP, Clinical Research, and CMO at Artivion (formerly CryoLife)

  CLINCAL EXPERTISE

  • 10 years at Mayo Clinic as a cardiologist and as an associate professor of Medicine
  • 21 years at Medtronic as a CO and senior VP. President of the $1.3B pain therapies business unit, general manager of the $1.4B implantable defibrillator business, and general manager of the Japan cardiac rhythm management and external defibrillator businesses
  • Lead clinical research departments including $8B cardiac and vascular group

  INNOVATION ENABLER

  • P/L management, launching new products and therapies, negotiating with FDA and CMS (Medicare), acquisition and integration of companies, and leading clinical research organizations
  • Board member of medical device and services companies, a hospital, and academic institutions

  COMMUNITY BUILDER

  • In addition to mentoring many employees, he was a member of the leadership team of the Medtronic Women’s Network

  Education

  • M.D. | Medical College of Virginia
  • Bachelor of Arts | University of Pennsylvania